SELVAS Healthcare, Inc. (KOSDAQ:208370)
4,250.00
+60.00 (1.43%)
At close: Apr 3, 2026
SELVAS Healthcare Revenue
In the year 2025, SELVAS Healthcare had annual revenue of 30.82B KRW, down -2.77%. SELVAS Healthcare had revenue of 10.20B in the quarter ending December 31, 2025, with 11.30% growth.
Revenue
30.82B
Revenue Growth
-2.77%
P/S Ratio
3.50
Revenue / Employee
240.82M
Employees
128
Market Cap
107.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.82B | -877.57M | -2.77% |
| Dec 31, 2024 | 31.70B | 1.89B | 6.34% |
| Dec 31, 2023 | 29.81B | 2.13B | 7.68% |
| Dec 31, 2022 | 27.69B | -1.40B | -4.82% |
| Dec 31, 2021 | 29.09B | 7.94B | 37.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.04B |
| DRGEM | 102.75B |
| JPI Healthcare | 52.79B |
| L&K Biomed | 38.92B |
| Hironic | 33.18B |
| Remed | 24.50B |
| Neofect | 16.05B |
| MEKICS CO., | 11.29B |